Drug profile · INN
retapamulin
ALTARGO
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
retapamulin (ALTARGO) is an FDA-listed pharmaceutical active ingredient. Associated with Almirall. Route of administration: topical. Current US regulatory status: approved.
Key facts
INN retapamulin
Brand ALTARGO
Route TOPICAL
Formulation OINTMENT
ATC code D06AX13
Originator Almirall
Frequently asked questions
What is retapamulin?
retapamulin (ALTARGO) is an FDA-listed pharmaceutical active ingredient. Associated with Almirall. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for retapamulin?
ALTARGO is a marketed brand name for retapamulin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of retapamulin?
retapamulin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.